Advertisement
Advertisement

Indicator

Free Access

Pay per View

Partial Free Access

Contact Person

Dr. Elinor Switzer

Managing Editor

Phone: +49 (0)711 - 2 29 87 63
Fax: +49 (0)711 - 2 29 87 65
send an Email


Archive

Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
DOI: http://dx.doi.org/10.1160/TH09-06-0349
Issue: 2010: 103/1 (Jan) pp. 1–249
Pages: 129-137
Ahead of Print: ###MANUSCRIPT_aheadofprint###

Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery

A decision analysis

M. Blondon (1), A. Perrier (1), M. Nendaz (1), M. Righini (2), F. Boehlen (2), M. Boulvain (3), P. De Moerloose (2)
(1) Division of General Internal Medicine, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland; (2) Division of Angiology and Hemostasis, Department of Internal Medicine, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland; (3) Department of Gynaecology and Obstetrics, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland

Keywords

low-molecular-weight heparin, Venous thrombosis, pregnancy, prophylaxis, cesarean section

Summary

Although venous thromboembolism (VTE) is the leading cause of maternal mortality in developed countries, the usefulness of preventive low-molecular-weight heparin (LMWH) after cesarean delivery remains a matter of controversy. It was the objective of this study to evaluate the usefulness of thromboprophylaxis with LMWH after cesarean delivery. A decision model was constructed to evaluate the risks and benefits associated with a seven-day LMWH prophylaxis, compared with none. All probabilities were obtained from literature according to the highest level of evidence. We performed our analysis on two different sets of outcomes (utilities and disutilities), to calculate the quality-adjusted life expectancy at three months. Finally, we calculated the outcomes for four hypothetical cases with different risk. Prophylaxis with LMWH yielded the highest quality-adjusted life expectancy, with a net gain of 1.5–2.8 quality-adjusted days. Sensitivity analyses showed the incidence of VTE after cesarean delivery and the haemorrhagic risk related to LMWH to be critical, at threshold values of 0.15–0.22% and 0.23–0.35%, respectively. In the hypothetical cases, LMWH was safe but only marginally more effective in women with no risk factors. In case of an emergency procedure, a body-mass index >25kg/m2, tobacco smoking, or any combination of these, reductions in VTE greatly outnumbered the increase in major haemorrhages, with a modest benefit on mortality. Our decision analysis suggests that the benefits of LMWH after cesarean delivery exceed the risks. This benefit is, however, very low in women with no risk factors.

You may also be interested in...

1.
Ali Seddighzadeh, Ranjith Shetty, Samuel Z. Goldhaber

Thromb Haemost 2007 98 3: 656-661

http://dx.doi.org/10.1160/TH07-04-0242

2.
André Kher1, Rupert Bauersachs2, Jorn Dalsgaard Nielsen3

Thromb Haemost 2007 97 4: 505-513

http://dx.doi.org/10.1160/TH06-10-0606

3.
Karim Abou-Nassar1, Michael J. Kovacs2, Susan R. Kahn3, Philip Wells1, Steve Doucette1, Tim Ramsay1, Anne Marie Clement1, Rshmi Khurana4, Karen MacKinnon2, Mark Blostein5, Susan Solymoss6, John Kingdom7, Matthew Sermer7, Evelyne Rey8, Marc Rodger1 for the TIPPS investigators

Thromb Haemost 2007 98 1: 163-171

http://dx.doi.org/10.1160/TH06-10-0574